Spire Healthcare Group (LSE:SPI) ROCE %: 5.92% (As of Dec. 2025)


LSE:SPI Spire Healthcare Group PLC LSE:SPI
73 GF Score
Price £2.18
GF Value £2.71
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Spire Healthcare Group ROCE %?

Spire Healthcare Group LSE:SPI -1.80% 73 ROCE % is 5.92% as of Dec. 2025. GuruFocus rates LSE:SPI with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Spire Healthcare Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 5.92%.

Spire Healthcare Group  (LSE:SPI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Spire Healthcare Group ROCE % Related Terms

Spire Healthcare Group ROCE % Historical Data

* Premium members only.

The historical data trend for Spire Healthcare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spire Healthcare Group ROCE % Chart

Spire Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.54 4.71 6.56 6.88 6.06

Spire Healthcare Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.29 7.23 6.60 6.23 5.92
LSE:SPI
73GF Score
Spire Healthcare Group PLC LSE:SPI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spire Healthcare Group ROCE % Calculation

Spire Healthcare Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=122.1/( ( (2343.2 - 341.7) + (2377.1 - 346.8) )/ 2 )
=122.1/( (2001.5+2030.3)/ 2 )
=122.1/2015.9
=6.06 %

Spire Healthcare Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=119.4/( ( (2364.5 - 362.4) + (2377.1 - 346.8) )/ 2 )
=119.4/( ( 2002.1 + 2030.3 )/ 2 )
=119.4/2016.2
=5.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.92% mean?
Spire Healthcare Group (LSE:SPI) has a ROCE % of 5.92% as of Dec. 2025.
Is Spire Healthcare Group's ROCE % too high?
Spire Healthcare Group's current ROCE % is 5.92%. The Healthcare Providers & Services industry median ROCE % is 6.41. Spire Healthcare Group's value of 5.92% is 7.6% below this industry median. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's ROCE % compare to HCA and THC?
Spire Healthcare Group's ROCE % of 5.92% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Spire Healthcare Group's value of 5.92% is 7.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current ROCE % of 5.92% is 7.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current ROCE % is 5.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (LSE:SPI) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.18 — trading 19.6% below its estimated fair value. The current ROCE % is 5.92% and 7.6% below the Healthcare Providers & Services industry median of 6.41. Spire Healthcare Group's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Spire Healthcare Group (LSE:SPI), the current ROCE % is 5.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spire Healthcare Group (LSE:SPI) Overvalued in 2026?

Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued. The current stock price of £2.18 is trading 19.6% below its estimated GF Value™ of £2.71. GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.

Key valuation signals for LSE:SPI:

  • ROCE %: 5.92%
  • GF Value™: £2.71 vs. price of £2.18 (19.6% below fair value)
  • GF Score™: 73/100 with 7 warning signs
  • Industry Position: 7.6% below the Healthcare Providers & Services median

No single metric tells the full story. See the LSE:SPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spire Healthcare Group Business Description

Other Exchanges SPIl:UKS00:Germany
Address 3 Dorset Rise, London, GBR, EC4Y 8EN
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score

Get the complete analysis for LSE:SPI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.18
Price
£2.71
GF Value